Summary
Thirteen patients whose hypertension had been resistant to conventional drug therapy, had minoxidil added to their regimen in doses from 5 to 60mg/day. All responded with satisfactory reductions of blood pressure to mean values of 149/90mm Hg (supine) and 143/89mm Hg (standing). A significant portion of their previous antihypertensive therapy was either greatly decreased or withdrawn completely. Although fluid retention occurred in most patients as the dose of minoxidil was increased, this could be successfully checked by the use of diuretics. It was considered that in addition to β-adrenoreceptor blocking drugs to control the reflexly induced cardiac stimulation, sufficiently aggressive diuretic therapy is mandatory to ensure the successful use of this drug. Haemodynamic evaluations in seven patients clearly showed that lowering of blood pressure was the result of decreases in peripheral vascular resistance as significant increases in the cardiac index occurred in all patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dormois, J.C.; Young, J.L. and Nies, A.S.: Minoxidil in severe hypertension: Value when conventional drugs have failed. American Heart Journal 90: 360–368 (1975).
Du Charme, D.W.; Freyburger, W.K.; Graham, B.E. and Carlson, R.G.: Pharmacologic properties of minoxidil: A new hypotensive agent. Journal of Pharmacology and Experimental Therapeutics 184: 662–670 (1973).
Gilmore, E.; Weil, J. and Chidsey, C: Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. New England Journal of Medicine 282: 521–527 (1970).
Hall, R.C. and Tyler, M.J.: A computer program to estimate cardiac output directly from dye-dilution curves. Journal of Applied Physiology 31: 145–147 (1971).
Hamilton, W.F.: Measurement of the cardiac output; in Dow (Ed.) Handbook of Physiology, Section 2, Vol. 1, p.551–584 American Physiological Society, Washington 1962).
Kim K.E.; Onesti, G.; Neff, M.S.; Greco, J.A.; Slifkin, R.F. and Swartz, C: Hemodynamic alterations in hypertension of chronic end-stage renal disease; in Onesti, Kim and Moyer (Eds) Hypertension: Mechanisms and Management, p.609–616 (Grune & Stratton, New York 1973).
O’Malley, K.; Velasco, M.; Wells, J. and McNay J.L.: Mechanisms of the hypotensive effect of propranolol in minoxidil treated hypertensive patients. Clinical Research 23(3): A191 (1975).
Pettinger, W.A. and Mitchell, H.C.: Minoxidil — an alternative to nephrectomy for refractory hypertension. New England Journal of Medicine 289: 167–171 (1973).
Sannerstedt, R.; Bronson, L.; Berglund, G. and Werkö L.: Minoxidil — haemodynamic and clinical experiences with anew peripheral vasodilator. Acta Medica Scandinavica 197: 409–414 (1975).
Wilburn, R.L.; Blaufuss, A. and Bennett, CM.: Longterm treatment of severe hypertension with minoxidil, propranolol and furosemide. Circulation 52: 706–713 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zacest, R., Frewin, D.B., Robinson, M.A. et al. Clinical and Haemodynamic Effects of Minoxidil in Refractory Hypertension. Drugs 11 (Suppl 1), 177–184 (1976). https://doi.org/10.2165/00003495-197600111-00036
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197600111-00036